The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase 2 trial of sintilimab (IBI 308) in combination with CAPEOX and bevacizumab (BBCAPX) as first-line treatment in patients with RAS-mutant, microsatellite stable, unresectable metastatic colorectal cancer.
 
Xuefeng Fang
No Relationships to Disclose
 
Chenhan Zhong
No Relationships to Disclose
 
Ning Zhu
No Relationships to Disclose
 
Shanshan Weng
No Relationships to Disclose
 
Hanguang Hu
No Relationships to Disclose
 
Jian Wang
No Relationships to Disclose
 
Qian Xiao
No Relationships to Disclose
 
Jianwei Wang
No Relationships to Disclose
 
Yongmao Song
No Relationships to Disclose
 
Lifeng Sun
No Relationships to Disclose
 
Dong Xu
No Relationships to Disclose
 
Xiujun Liao
No Relationships to Disclose
 
Caixia Dong
No Relationships to Disclose
 
Suzhan Zhang
No Relationships to Disclose
 
Jun Li
No Relationships to Disclose
 
Ke-Feng Ding
No Relationships to Disclose
 
Ying Yuan
No Relationships to Disclose